This is an infection caused by a type of mold called Aspergillus. It can affect different parts of the body, like the lungs, sinuses, or skin. It's important to see a doctor if you suspect you might have this, as it can sometimes be serious.
Every report comes from a Lived member, sent anonymously.
Have you tried Vfend (Voriconazole) for Aspergillosis?
Aspergillosis is a group of illnesses caused by Aspergillus, a mold that grows on decaying leaves, compost, stored grain and dust, indoors and out. Nearly everyone breathes in its tiny spores every day without any problem. Illness develops when the lungs or the immune system cannot clear them normally, so aspergillosis mostly affects people who already have a lung condition or a weakened immune system. The word covers three quite different problems. Allergic bronchopulmonary aspergillosis (ABPA) is an allergic reaction to the mold in the airways, usually in people with asthma or cystic fibrosis, and it shows up as hard-to-control wheezing, cough and thick brownish mucus plugs. Chronic pulmonary aspergillosis is a slow infection that settles in lung damaged by an earlier illness such as tuberculosis; it can form a fungus ball (aspergilloma) inside an old lung cavity and cause months of cough, tiredness, weight loss or coughing up blood. Invasive aspergillosis is a fast, serious infection in people with very weak immune defenses, in which the mold grows into lung tissue and can spread to other organs. Knowing which form someone has matters, because the treatment and the level of urgency are very different.
Contact with Aspergillus is almost unavoidable, so the main risk lies in the person rather than the exposure. Each form has its own risk group. ABPA develops mainly in people with asthma or cystic fibrosis whose immune systems overreact to the mold. Chronic infection and fungus balls occur in people whose immune systems work reasonably well but whose lungs have cavities or scarring, for example after tuberculosis or from another long-term lung disease. Invasive aspergillosis occurs mostly in people whose infection-fighting white blood cells are low or not working well: during chemotherapy for leukemia and other blood cancers, after a stem cell or organ transplant, with long courses of high-dose steroids or other immune-suppressing medicines, and sometimes with advanced HIV infection. Doctors also now see it in some people in intensive care, including after severe influenza or COVID-19. For people at high risk of invasive infection, guidelines advise reasonable steps to limit heavy mold exposure, such as avoiding gardening, spreading mulch or compost, and close contact with construction or renovation dust.
Because Aspergillus is everywhere, finding it in a single sputum sample does not by itself prove illness. Diagnosis rests on putting together the person's risk factors, symptoms, imaging and laboratory evidence, and the tests used depend on which form is suspected. A CT (computed tomography) scan of the chest is the central imaging test. It shows patterns a plain X-ray can miss, such as nodules, cavities or a fungus ball. For suspected invasive infection, doctors may test blood or fluid from the lungs for galactomannan, a sugar released by the mold, and may use bronchoscopy (a thin camera passed into the airways to collect samples) or a needle biopsy to confirm the fungus and rule out other infections. Chronic pulmonary aspergillosis is diagnosed when lung cavities, nodules or a fungus ball have been present for at least three months, there is evidence of Aspergillus (most often a positive Aspergillus IgG antibody blood test, a sign of a lasting immune response to the mold rather than an allergy), and other causes such as tuberculosis have been ruled out. For ABPA, the key blood tests measure IgE, the antibody involved in allergy. A diagnosis usually requires evidence of allergy to Aspergillus plus a total IgE level of 500 international units per milliliter or higher (well above the usual range), along with at least two other findings: Aspergillus IgG antibodies, a raised count of eosinophils (allergy-related white blood cells), or typical changes on a CT scan, such as widened airways (bronchiectasis) or mucus plugs. Current guidelines suggest testing for Aspergillus allergy in adults newly diagnosed with asthma at specialist centers and in children whose asthma is difficult to treat.
Treatment is tailored to the form of aspergillosis, so the same diagnosis can mean watchful monitoring for one person and urgent hospital care for another. For ABPA, the aim is to calm the allergic inflammation and prevent permanent airway damage. A flare is treated with an oral steroid such as prednisone or prednisolone, or with itraconazole, an antifungal pill that reduces the amount of mold in the airways. The two are combined mainly for people whose flares keep returning. Steroids work well for flares, but repeated or long courses carry many side effects, including raised blood sugar, and itraconazole can reduce how much steroid someone needs. People who have ABPA but no symptoms are not usually treated. Good control of the underlying asthma or cystic fibrosis remains part of the plan. For a single fungus ball that causes no symptoms and is not growing, doctors often simply monitor it with repeat scans. If it causes bleeding or other symptoms, surgery to remove it is the main treatment when it is safe to operate. Chronic pulmonary aspergillosis that causes symptoms or is getting worse is treated with an antifungal pill, usually itraconazole or voriconazole, for at least six months and sometimes for years. Treatment aims to ease cough and tiredness, stop bleeding and keep the disease from spreading through the lung. Coughing up blood can also be controlled with tranexamic acid (a medicine that helps blood clot) or bronchial artery embolization, a procedure that blocks the bleeding blood vessel from inside. Invasive aspergillosis needs prompt antifungal treatment, usually in hospital at first. Voriconazole (Vfend) is the usual first choice, given by vein or by mouth; isavuconazole (Cresemba) or a form of amphotericin B given by vein are alternatives. Treatment typically lasts at least 6 to 12 weeks and often longer, depending on how weak the immune system remains and how the infection responds. Recovery of the immune system, by lowering immune-suppressing medicines where possible or waiting for white blood cell counts to recover, strongly affects whether treatment succeeds. Some high-risk patients, such as people with long periods of very low white blood cell counts during leukemia treatment or certain transplant recipients, are given a preventive antifungal such as posaconazole (Noxafil). The azole antifungals used across all these forms (itraconazole, voriconazole, posaconazole and isavuconazole) interact with many other medicines, including the transplant drugs tacrolimus and cyclosporine and steroid inhalers for asthma such as budesonide or fluticasone, so doctors often check blood levels of the antifungal and adjust other doses. Liver blood tests are part of routine monitoring. Voriconazole also makes the skin more sensitive to sunlight, and over long courses it raises the risk of skin cancer, so sun protection matters during treatment.
The course depends largely on the form. ABPA usually improves with treatment, but flares commonly return, so many people have a long-term relationship with an asthma or lung specialist, with periodic IgE blood tests and scans to catch a flare before it damages the airways. Over years, untreated or repeated flares can leave lasting scarring and widened airways. Chronic pulmonary aspergillosis is a long-term condition. People on months or years of antifungal pills have regular checkups, blood tests for drug levels and liver function, and repeat scans to see whether the disease is stable or shrinking. Some feel noticeably better within months, while others mainly stay stable, and the infection can return after treatment stops. Side effects or drug interactions sometimes mean switching from one antifungal to another. Invasive aspergillosis is the most serious form. The outlook depends heavily on how quickly treatment starts and on the underlying illness, especially whether the immune system recovers. Recovery often overlaps with cancer treatment or transplant care, so the antifungal plan is coordinated with those teams, and people may continue an antifungal for months or take one preventively during later periods of high risk. Follow-up CT scans, usually from about two weeks into treatment, help show whether the infection is responding.
See a doctor if asthma or cystic fibrosis is becoming harder to control, with more wheezing or brown mucus plugs, or if you have a cough, tiredness or weight loss that lasts for weeks and you have a history of lung damage such as tuberculosis. These are reasons for a planned assessment, including a chest scan and blood tests. If you have a weakened immune system, for example during chemotherapy, after a transplant or while taking high-dose steroids, contact your care team right away if you develop a fever, a new cough, chest pain or new shortness of breath. In this group, invasive aspergillosis can progress quickly and early treatment matters. Follow any specific fever instructions your cancer or transplant team has given you. Contact your doctor the same day if you cough up any blood, even streaks or small amounts, especially if you have a fungus ball or chronic aspergillosis. Small bleeds can come before a heavier one and may mean treatment needs to start or change. Get emergency care if you cough up more than a few teaspoons of blood or become severely short of breath. Bleeding from the lung can be heavy, especially with a fungus ball or chronic infection, and needs immediate treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Aspergillosis is like, what's helped you, or ask the community a question.